Compare Clipan Finance Indonesia Tbk. (CFIN) vs Hetzer Medical Indonesia Tbk. (MEDS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Clipan Finance Indonesia Tbk. vs Hetzer Medical Indonesia Tbk. — how do they compare? Clipan Finance Indonesia Tbk. trades at Rp350 (market cap 1.39T, 781.5K 24h volume), while Hetzer Medical Indonesia Tbk. trades at Rp72 (market cap 114.06B, 23.06M 24h volume). The key difference: Clipan Finance Indonesia Tbk. is far larger — about 12.2× Hetzer Medical Indonesia Tbk.'s market cap, and Hetzer Medical Indonesia Tbk. is more actively traded (23.06M versus 781.5K). Which is the better fit depends on your goals.
| CFIN | MEDS | |
|---|---|---|
Market Cap | 1.39T | 114.06B |
Volume | 781.5K | 23.06M |
Lot | 7.82K | 230.55K |
Turnover | 274.69M | 1.68B |
Average Price | 351.5 | 72.75 |
Value | 274.69M | 1.68B |
Indicative Equilibrium Price | 350 | 72 |
Indicative Equilibrium Volume | 3 | 1.56K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Clipan Finance Indonesia Tbk.
PT Clipan Finance Indonesia Tbk (the Company) was established on January 15, 1982 based on the notarial deed No.47 of Kartini Muljadi SH. The Deed of establishment was approval by the Ministry of Justice with his decision letter No. C2-396-HT.01Th.82 on August 2, 1982 and was published on State Gazette No.79 dated October 1, 1982, Supplement No.1189. The article of association have been change several times, most recently on June 29 1998 concerning among others, the change in the Authorized capital and par value of share. The Company is located in Jakarta and the branches is in Denpasar. The Company is affiliated by Panin Group.
Read more on CFIN →About Hetzer Medical Indonesia Tbk.
PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.
Read more on MEDS →
